Skip to content

Peri-Implant Healing Around Two Different Machined-Collar Designs After 25 Years of Function

Prospective Randomised Clinical Trial Evaluating the Effects of Two Different Implant Collar Designs on Peri-Implant Healing and Functional Osseointegration After 25 Years of Function With Full Arch Mandibular Prostheses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03862482
Enrollment
22
Registered
2019-03-05
Start date
2019-06-03
Completion date
2019-12-31
Last updated
2021-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Jaw, Edentulous

Keywords

Dental Implants, Microtextured Fixture, Machined Collar

Brief summary

Brånemark System® dental implant osseointegration was introduced in 1965 as a novel approach to the replacement of missing teeth. Although this implant's machined, screw-shaped surface had excellent, well-documented, short- and long-term clinical success (Adell, R. 1987; Albrektsson, T., et al., 1981; Albrektsson, T., et al., 1986; Brånemark, P-I. , 1983; Brånemark P-I. 1987), newer implant designs were introduced that could enhance fusion of the implant to jaw bones, and better resist functional forces. One such implant, Screw-Vent®, has a fixture macro structure very similar to that of the Brånemark® implant. However, its fixture surface was acid etched (1-3µm) which could enhance osseointegration, and it has a longer, narrower machined internal-hex, friction-fit collar that could better resist functional forces.These characteristics should lead to less bone loss (Niznick, G. A., 1989). However, one clinical study (De Bruyen, et al., 1992) reported greater short-term bone loss with this implant compared to the Brånemark® implant, possibly due to its longer machined collar, and advocated long-term clinical studies. Therefore, this prospective within-subject clinical trial was undertaken in 1993 to first compare the Brånemark® implant with another implant, Swede-Vent®, a copy of the Brånemark® macro structure except for its fixture surface that was identically micro textured as that of Screw-Vent® by the same manufacturer. The effect on bone healing could then be compared between Brånemark®'s machined and Swede-Vent®'s micro textured fixture surfaces in the short- and long-terms. Since Screw-Vent®'s fixture surface was identically micro textured as that of Swede-Vent®, the investigators could then evaluate and compare the effects on bone healing of Screw-Vent®'s longer, narrower, internal-connection machined collar to the identical shorter, wider, external-connection machined collars of the Swede-Vent® and Brånemark® implants. All three two-part, platform-matched, parallel-wall implants were made of commercially pure titanium, had a very similar fixture macro design, were approved by the Food and Drug Administration (USA) and Health and Welfare Canada, and were commercially available in North America. Brånemark® and Screw-Vent® implants are still available, but the Swede-Vent® implant is not.

Detailed description

Therefore, between 1993 and 1996, 58 of 60 eligible participants had been recruited into a prospective, randomized clinical trial. This trial had been peer reviewed, had received ethical approval, and had taken place at the Université de Montréal's Faculty of Dental Medicine and its affiliated hospital dental department. Follow-up documentation occurred at one year, two years, and 15 to 20 years following prostheses attachment (ClinicalTrials Identification Number NCT01641198), and the results were published (Camarda, et al., 2018). The present study reports on data collected at the 25-year (24.6 ± 0.19 years, mean ± SE) follow-up (ClinicalTrials Identification Number NCT03862482), focusing specifically on the evaluation and comparison of the effects on peri-implant healing and functional osseointegration of the two different machined collar designs. That is to say, the identical shorter, wider, external-connection Brånemark® and Swede-Vent® collars versus the longer, narrower, internal-connection Screw-Vent® collar. Twenty-two of the original participants (41.5%, age 71.1 ± 1.2 years, 11 women, 110 implants) were enrolled into this study. All study procedures were performed in accordance with the Helsinki Declaration and its later amendments, and all participants signed informed consent documents prior to inclusion into this study.

Interventions

DEVICEBrånemark® 2, Swede-Vent® 2, Screw-Vent® 1 (Configuration 1)

Brånemark® implant placed at sites 2 (left medial) and 5 (right distal), Swede-Vent® implant placed at sites 1 (left distal) and 4 (right medial), Screw-Vent® implant placed at site 3 (para symphysis)

DEVICEBrånemark® 1, Swede-Vent® 2, Screw-Vent® 2 (Configuration 2)

Brånemark® implant placed at site 3 (para symphysis), Swede-Vent® implant placed at sites 2 (left medial) and 5 (right distal), Screw-Vent® implant placed at sites 1 (left distal) and 4 (right medial)

DEVICEBrånemark® 2, Swede-Vent® 1, Screw-Vent® 2 (Configuration 3)

Brånemark® implant placed at sites 1 (left distal) and 4 (right medial), Swede-Vent® implant placed at site 3 (para symphysis), Screw-Vent® implant placed at sites 2 (left medial) and 5 (right distal)

Sponsors

Université de Montréal
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Masking description

For the initial study, a statistician had prepared a sampling design that included three configuration diagrams. Each diagram identified five implants of the three types, and showed how one of each type was to be placed in a cyclical, side-by-side, rotating fashion at five sites between mental foramena. Allocation concealment by the project coordinator then allowed 20 participants to receive Configuration 1, 19 had Configuration 2, and 19 had Configuration 3. Configuration diagram (but not number) was stored inside each chart, and only shown to the operating team at the time of surgery. The present study is a continuation of this clinical trial, including data collected at the 25-year (24.6 ± 0.19 years, mean ± SE) follow-up. Twenty-two of the original participants (41.5%, age 71.1 ± 1.2 years, 11 women, 110 implants) were enrolled in this study. Eight participants (40 implants) received Configuration 1, 8 (40 implants) had Configuration 2, and 6 (30 implants) had Configuration 3.

Eligibility

Sex/Gender
ALL
Age
48 Years to 82 Years
Healthy volunteers
Yes

Inclusion criteria

* non-smoker * no temporomandibular joint (TMJ) disorder or facial pain * having participated in the original study (1993 - 1996) at which time the minimum participants' age was 25 years and the maximum 56 years

Exclusion criteria

* refusal to sign informed consent documents

Design outcomes

Primary

MeasureTime frameDescription
Comparison of Distance Between First Bone to Implant Contact Point (fBIC) and Microgap (MG), After 25 Years of Function, Between All B, All SW, and All SC Dental Implant Units in All Three ConfigurationsAfter 25 years (24.6 ± 0.19 years, mean ± SE) of functionDistance between first bone-to-implant contact point (fBIC) and microgap (MG) at the crest was measured (mm) at mesial and distal sides of each implant/abutment complex on conventional peri-apical radiographs using a standardized equipment and measurement protocol (Camarda, et al., 2018) after 25 years of function. Values fBIC-MG (Mean ± SE) (- for bone loss) were calculated, recorded and compared between all B and all SW, between all B and all SC and between all SW and all SC dental implant units in all three Configurations

Secondary

MeasureTime frameDescription
Comparison of Prosthesis, Abutment, and Implant Mobility or Looseness: Absence (0) or Presence (1) of Mobility or Looseness After 25 Years of FunctionAfter 25 years (24.6 ± 0.19 years, mean ± SE) of functionMobility was measured by applying manual pressure on the handles of two instruments, each placed on opposite sides of the prostheses and abutments, and was recorded as 0 (no mobility or looseness) or 1 (mobility or looseness). Values (Mean ± SE) were calculated, recorded and compared between B and SW, between B and SC and between SW and SC for Configuration 1 (Brånemark® 2, Swede-Vent® 2, Screw-Vent® 1), Configuration 2 (Brånemark® 1, Swede-Vent® 2, Screw-Vent® 2), and Configuration 3 (Brånemark® 2, Swede-Vent® 1, Screw-Vent® 2)
Comparison of Soft Tissue Healing: Height (mm) of Keratinized Tissue After 25 Years of FunctionAfter 25 years (24.6 ± 0.19 years, mean ± SE) of functionHeight of the keratinized tissue was measured (mm) using a ColorVue UNC12 Hu-Friedy probe on the buccal and lingual implant/abutment surfaces. Values (Mean ± SE) were calculated, recorded and compared between B and SW, between B and SC and between SW and SC for Configuration 1 (Brånemark® 2, Swede-Vent® 2, Screw-Vent® 1), Configuration 2 (Brånemark® 1, Swede-Vent® 2, Screw-Vent® 2), and Configuration 3 (Brånemark® 2, Swede-Vent® 1, Screw-Vent® 2)
Comparison of Soft Tissue Healing: Absence (0) or Presence (1) of Plaque and/or Gingival Bleeding After 25 Years of FunctionAfter 25 years (24.6 ± 0.19 years, mean ± SE) of functionAbsence (0) or presence (1) of plaque and/or gingival bleeding on probing was evaluated using the dichotomous/binary plaque index (dPI) (Galgut, P. A., 1999) and bleeding index (dBI), respectively (Galgut, P.A., 1999). Values (Mean ± SE) were compared between B and SW, between B and SC and between SW and SC for Configuration 1 (Brånemark® 2, Swede-Vent® 2, Screw-Vent ®1), Configuration 2 (Brånemark® 1, Swede-Vent® 2, Screw-Vent® 2), and Configuration 3 (Brånemark® 2, Swede-Vent® 1, Screw-Vent® 2)
Comparison of Soft Tissue Healing: Absence (0) or Presence (1) of Purulent Exudate After 25 Years of FunctionAfter 25 years (24.6 ± 0.19 years, mean ± SE) of functionAbsence (0) or presence (1) of purulent exudate on probing was evaluated. Values (Mean ± SE) were recorded, and compared between B and SW, between B and SC and between SW and SC for Configuration 1 (Brånemark® 2, Swede-Vent® 2, Screw-Vent® 1), Configuration 2 (Brånemark® 1, Swede-Vent® 2, Screw-Vent® 2), and Configuration 3 (Brånemark® 2, Swede-Vent® 1, Screw-Vent® 2)
Comparison of Soft Tissue Healing: Probing Depth (mm) After 25 Years of FunctionAfter 25 years (24.6 ± 0.19 years, mean ± SE) of functionUsing a ColorVue UNC12 Hu-Friedy probe, probing depth was measured (mm) on the buccal, lingual, mesial and distal implant/abutment surfaces. Values (Mean ± SE) were calculated, recorded and compared between B and SW, between B and SC and between SW and SC for Configuration 1(Brånemark® 2, Swede-Vent® 2, Screw-Vent® 1), Configuration 2 (Brånemark® 1, Swede-Vent® 2, Screw-Vent® 2), and Configuration 3 (Brånemark® 2, Swede-Vent ®1, Screw-Vent® 2)

Other

MeasureTime frameDescription
Comparison of Two Measurement Systems Used to Evaluate Peri-implant Bone Healing After 25 Years of FunctionAfter 25 years (24.6 ± 0.19 years, mean ± SE) of functionConventional peri-apical radiology and phosphor-plate digital technology (Digora System™, Digora OptimeTM, Sporedex Dental Co., Tuusula, Finland) were used with the standardized equipment to take peri-apical radiographs on 95 implant/abutment units (Camarda, et al., 2018; Bhaskaran, et al., 2005). Following calibration, the distance between the first-bone-to-implant-contact-point and the crestal-microgap (fBIC-MG) was measured (mm) at the mesial and distal aspects of each implant/abutment unit after 25 years of function. Values (Mean ± SE) fBIC-MG were recorded for each of the two measurement systems. ICC (Intraclass Correlation Coefficient, two-way, mixed effect model) and Bland-Altman Limits of agreement (Bland & Altman, 1986) were used to evaluate the level of agreement between the two systems

Countries

Canada

Participant flow

Recruitment details

Recruitment date: May 1st - May 30th, 2019. Recruitment location: Faculty of Dental Medicine

Participants by arm

ArmCount
Brånemark® 2, Swede-Vent® 2, Screw-Vent® 1 (Configuration 1)
Device placement: B (Brånemark® dental implant unit) placed at sites 2 (left medial) and 5 (right distal), SW (Swede-Vent® dental implant unit) placed at sites 1 (left distal) and 4 (right medial), SC (Screw-Vent® dental implant unit) placed at site 3 (para symphysis) for a total of 40 dental implant units (16 B, 16 SW, 8 SC), all between mandibular foramen
8
Brånemark® 2, Swede-Vent® 2, Screw-Vent® 1 (Configuration 1)
Device placement: B (Brånemark® dental implant unit) placed at sites 2 (left medial) and 5 (right distal), SW (Swede-Vent® dental implant unit) placed at sites 1 (left distal) and 4 (right medial), SC (Screw-Vent® dental implant unit) placed at site 3 (para symphysis) for a total of 40 dental implant units (16 B, 16 SW, 8 SC), all between mandibular foramen
40
Brånemark® 1, Swede-Vent® 2, Screw-Vent® 2 (Configuration 2)
Device placement: B (Brånemark® dental implant unit) placed at site 3 (para symphysis), SW (Swede-Vent® dental implant unit) placed at sites 2 (left medial) and 5 (right distal), SC (Screw-Vent® dental implant unit) placed at sites 1 (left distal) and 4 (right medial) for a total of 40 dental implant units (eight B, 16 SW, 16 SC), all between mandibular foramen
8
Brånemark® 1, Swede-Vent® 2, Screw-Vent® 2 (Configuration 2)
Device placement: B (Brånemark® dental implant unit) placed at site 3 (para symphysis), SW (Swede-Vent® dental implant unit) placed at sites 2 (left medial) and 5 (right distal), SC (Screw-Vent® dental implant unit) placed at sites 1 (left distal) and 4 (right medial) for a total of 40 dental implant units (eight B, 16 SW, 16 SC), all between mandibular foramen
40
Brånemark® 2, Swede-Vent® 1, Screw-Vent® 2 (Configuration 3)
Device placement: B (Brånemark® dental implant unit) placed at sites 1 (left distal) and 4 (right medial), SW (Swede-Vent® dental implant unit) placed at site 3 (para symphysis), SC (Screw-Vent® dental implant unit) placed at sites 2 (left medial) and 5 (right distal) for a total of 30 dental implant units (12 B, six SW, 12 SC), all between mandibular foramen
6
Brånemark® 2, Swede-Vent® 1, Screw-Vent® 2 (Configuration 3)
Device placement: B (Brånemark® dental implant unit) placed at sites 1 (left distal) and 4 (right medial), SW (Swede-Vent® dental implant unit) placed at site 3 (para symphysis), SC (Screw-Vent® dental implant unit) placed at sites 2 (left medial) and 5 (right distal) for a total of 30 dental implant units (12 B, six SW, 12 SC), all between mandibular foramen
30
Total132

Baseline characteristics

CharacteristicBrånemark® 2, Swede-Vent® 2, Screw-Vent® 1 (Configuration 1)TotalBrånemark® 2, Swede-Vent® 1, Screw-Vent® 2 (Configuration 3)Brånemark® 1, Swede-Vent® 2, Screw-Vent® 2 (Configuration 2)
Age, Customized
Age (Years): Mean ± Standard Deviation
69.4 years
STANDARD_DEVIATION 6.12
70.45 years
STANDARD_DEVIATION 5.34
70.5 years
STANDARD_DEVIATION 4.11
71.5 years
STANDARD_DEVIATION 5.09
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
8 Participants22 Participants6 Participants8 Participants
Sex: Female, Male
Female
4 Participants11 Participants2 Participants5 Participants
Sex: Female, Male
Male
4 Participants11 Participants4 Participants3 Participants
Total number of implant units per study arm40 Number count110 Number count30 Number count40 Number count

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 80 / 80 / 6
other
Total, other adverse events
0 / 80 / 80 / 6
serious
Total, serious adverse events
0 / 80 / 80 / 6

Outcome results

Primary

Comparison of Distance Between First Bone to Implant Contact Point (fBIC) and Microgap (MG), After 25 Years of Function, Between All B, All SW, and All SC Dental Implant Units in All Three Configurations

Distance between first bone-to-implant contact point (fBIC) and microgap (MG) at the crest was measured (mm) at mesial and distal sides of each implant/abutment complex on conventional peri-apical radiographs using a standardized equipment and measurement protocol (Camarda, et al., 2018) after 25 years of function. Values fBIC-MG (Mean ± SE) (- for bone loss) were calculated, recorded and compared between all B and all SW, between all B and all SC and between all SW and all SC dental implant units in all three Configurations

Time frame: After 25 years (24.6 ± 0.19 years, mean ± SE) of function

Population: 22 participants in all Configurations contributed 110 implant units (40 Configuration 1, 40 Configuration 2, and 30 Configuration 3). One implant unit (SW, Configuration 1) had fractured, and two implant units (B and SW, Configuration 2) were excluded due to technical difficulties with radiographic technique. Consequently, 107 implant units were were analyzed.

ArmMeasureGroupValue (MEAN)Dispersion
All Participants (Configurations 1, 2, and 3)Comparison of Distance Between First Bone to Implant Contact Point (fBIC) and Microgap (MG), After 25 Years of Function, Between All B, All SW, and All SC Dental Implant Units in All Three ConfigurationsTotal 35 Brånemark® dental implant units analyzed for all three Configurations-0.85 mmStandard Error 0.18
All Participants (Configurations 1, 2, and 3)Comparison of Distance Between First Bone to Implant Contact Point (fBIC) and Microgap (MG), After 25 Years of Function, Between All B, All SW, and All SC Dental Implant Units in All Three ConfigurationsTotal 36 Swede-Vent® dental implant units analyzed for all three Configurations-1.00 mmStandard Error 0.18
All Participants (Configurations 1, 2, and 3)Comparison of Distance Between First Bone to Implant Contact Point (fBIC) and Microgap (MG), After 25 Years of Function, Between All B, All SW, and All SC Dental Implant Units in All Three ConfigurationsTotal 36 Screw-Vent® dental implant units analyzed for all three Configurations-1.77 mmStandard Error 0.18
Comparison: Total 35 Brånemark® implants analyzed for all Configurations. Size difference expected 0.95 bone level change between B/SW/SC. Sample size 16 participants ensured 80% power to reject null hypothesis (two-sided Bonferroni-adjusted α level 0.017, pairwise comparisons between implant groups). Repeated measures ANOVA. Mixed models, repeated measures within subject. Implant type/site/configuration independent variables (length covariate). (B/SW/SC lengths compared with Kruskal-Wallis test)p-value: <0.0595% CI: [-1.22, -0.49]ANOVA
Comparison: Total 36 Swede-Vent® implants analyzed for all Configurations. Size difference expected 0.95 bone level change between B/SW/SC. Sample size 16 participants ensured 80% power to reject null hypothesis (two-sided Bonferroni-adjusted α level 0.017, pairwise comparisons between implant groups). Repeated measures ANOVA. Mixed models, repeated measures within subject. Implant type/site/configuration independent variables (length covariate). (B/SW/SC lengths compared with Kruskal-Wallis test)p-value: <0.0595% CI: [-1.35, -0.64]ANOVA
Comparison: Total 36 Screw-Vent® implants analyzed for all Configurations. Size difference expected 0.95 bone level change between B/SW/SC. Sample size 16 participants ensured 80% power to reject null hypothesis (two-sided Bonferroni-adjusted α level 0.017, pairwise comparisons between implant groups). Repeated measures ANOVA. Mixed models, repeated measures within subject. Implant type/site/configuration independent variables (length covariate). (B/SW/SC lengths compared with Kruskal-Wallis test)p-value: <0.0595% CI: [-2.13, -1.41]ANOVA
Secondary

Comparison of Prosthesis, Abutment, and Implant Mobility or Looseness: Absence (0) or Presence (1) of Mobility or Looseness After 25 Years of Function

Mobility was measured by applying manual pressure on the handles of two instruments, each placed on opposite sides of the prostheses and abutments, and was recorded as 0 (no mobility or looseness) or 1 (mobility or looseness). Values (Mean ± SE) were calculated, recorded and compared between B and SW, between B and SC and between SW and SC for Configuration 1 (Brånemark® 2, Swede-Vent® 2, Screw-Vent® 1), Configuration 2 (Brånemark® 1, Swede-Vent® 2, Screw-Vent® 2), and Configuration 3 (Brånemark® 2, Swede-Vent® 1, Screw-Vent® 2)

Time frame: After 25 years (24.6 ± 0.19 years, mean ± SE) of function

Population: 22 participants in all Configurations contributed 110 implants (B=36, SW=38, SC=36). One implant (B Configuration 1) had fractured; two (B and SW Configuration 2) had technical issues. 107 implants were analysed after 25 years of function. Values (Mean ± SE) were calculated, recorded and compared between all B and all SW, between all B and all SC and between all SW and all SC implant units in all three Configurations

ArmMeasureGroupValue (NUMBER)
All Participants (Configurations 1, 2, and 3)Comparison of Prosthesis, Abutment, and Implant Mobility or Looseness: Absence (0) or Presence (1) of Mobility or Looseness After 25 Years of FunctionTotal 35 Brånemark® implants analyzed for all 3 Configurations0 Implants
All Participants (Configurations 1, 2, and 3)Comparison of Prosthesis, Abutment, and Implant Mobility or Looseness: Absence (0) or Presence (1) of Mobility or Looseness After 25 Years of FunctionTotal 36 Swede-Vent® implants analyzed for all 3 Configurations0 Implants
All Participants (Configurations 1, 2, and 3)Comparison of Prosthesis, Abutment, and Implant Mobility or Looseness: Absence (0) or Presence (1) of Mobility or Looseness After 25 Years of FunctionTotal 36 Screw-Vent® implants analyzed for all 3 Configurations.0 Implants
Secondary

Comparison of Soft Tissue Healing: Absence (0) or Presence (1) of Plaque and/or Gingival Bleeding After 25 Years of Function

Absence (0) or presence (1) of plaque and/or gingival bleeding on probing was evaluated using the dichotomous/binary plaque index (dPI) (Galgut, P. A., 1999) and bleeding index (dBI), respectively (Galgut, P.A., 1999). Values (Mean ± SE) were compared between B and SW, between B and SC and between SW and SC for Configuration 1 (Brånemark® 2, Swede-Vent® 2, Screw-Vent ®1), Configuration 2 (Brånemark® 1, Swede-Vent® 2, Screw-Vent® 2), and Configuration 3 (Brånemark® 2, Swede-Vent® 1, Screw-Vent® 2)

Time frame: After 25 years (24.6 ± 0.19 years, mean ± SE) of function

Population: 22 participants in all Configurations contributed 110 units (B=36, SW=38, SC=36). 107 were analyzed (B=35. SW=36, SC=36). fBIC-MG was measured at mesial and distal sides of each unit after 25 years of function. Mean (Mean ± SE) values were calculated, recorded and compared between all B and all SW, between all B and all SC and between all SW and all SC dental implant units in all three Configurations

ArmMeasureGroupValue (MEAN)Dispersion
All Participants (Configurations 1, 2, and 3)Comparison of Soft Tissue Healing: Absence (0) or Presence (1) of Plaque and/or Gingival Bleeding After 25 Years of FunctionTotal 35 Brånemark® dental implant units analyzed for all three Configurations. Plaque Mean dPI0.40 score on a scaleStandard Error 0.06
All Participants (Configurations 1, 2, and 3)Comparison of Soft Tissue Healing: Absence (0) or Presence (1) of Plaque and/or Gingival Bleeding After 25 Years of FunctionTotal 36 Swede-Vent® dental implant units analyzed for all three Configurations. Plaque Mean dPI0.42 score on a scaleStandard Error 0.06
All Participants (Configurations 1, 2, and 3)Comparison of Soft Tissue Healing: Absence (0) or Presence (1) of Plaque and/or Gingival Bleeding After 25 Years of FunctionTotal 36 Screw-Vent® dental implant units analyzed for all three Configurations. Plaque Mean dPI0.43 score on a scaleStandard Error 0.06
All Participants (Configurations 1, 2, and 3)Comparison of Soft Tissue Healing: Absence (0) or Presence (1) of Plaque and/or Gingival Bleeding After 25 Years of FunctionTotal 35 Brånemark® dental implant units analyzed for all three Configurations. Bleeding Mean dBI0.48 score on a scaleStandard Error 0.06
All Participants (Configurations 1, 2, and 3)Comparison of Soft Tissue Healing: Absence (0) or Presence (1) of Plaque and/or Gingival Bleeding After 25 Years of FunctionTotal 36 Swede-Vent dental implant units analyzed for all three Configurations. Bleeding Mean dBI0.47 score on a scaleStandard Error 0.05
All Participants (Configurations 1, 2, and 3)Comparison of Soft Tissue Healing: Absence (0) or Presence (1) of Plaque and/or Gingival Bleeding After 25 Years of FunctionTotal 36 Screw-Vent® dental implant units analyzed for all three Configurations. Bleeding Mean dBI0.44 score on a scaleStandard Error 0.06
Secondary

Comparison of Soft Tissue Healing: Absence (0) or Presence (1) of Purulent Exudate After 25 Years of Function

Absence (0) or presence (1) of purulent exudate on probing was evaluated. Values (Mean ± SE) were recorded, and compared between B and SW, between B and SC and between SW and SC for Configuration 1 (Brånemark® 2, Swede-Vent® 2, Screw-Vent® 1), Configuration 2 (Brånemark® 1, Swede-Vent® 2, Screw-Vent® 2), and Configuration 3 (Brånemark® 2, Swede-Vent® 1, Screw-Vent® 2)

Time frame: After 25 years (24.6 ± 0.19 years, mean ± SE) of function

Population: 22 participants in all Configurations contributed 110 units (B=36, SW=38, SC=36). 107 were analyzed (B=35. SW=36, SC=36). fBIC-MG was measured at mesial and distal sides of each unit after 25 years of function. Mean (Mean ± SE) values were calculated, recorded and compared between all B and all SW, between all B and all SC and between all SW and all SC dental implant units in all three Configurations

ArmMeasureGroupValue (NUMBER)
All Participants (Configurations 1, 2, and 3)Comparison of Soft Tissue Healing: Absence (0) or Presence (1) of Purulent Exudate After 25 Years of FunctionTotal 35 Brånemark® dental implant units analyzed for all three Configurations. Purulent exudate0 Implants.
All Participants (Configurations 1, 2, and 3)Comparison of Soft Tissue Healing: Absence (0) or Presence (1) of Purulent Exudate After 25 Years of FunctionTotal 36 Swede-Vent dental implant units analyzed for all three Configurations. Purulent exudate1 Implants.
All Participants (Configurations 1, 2, and 3)Comparison of Soft Tissue Healing: Absence (0) or Presence (1) of Purulent Exudate After 25 Years of FunctionTotal 36 Screw-Vent® dental implant units analyzed for all three Configurations. Purulent exudate0 Implants.
Secondary

Comparison of Soft Tissue Healing: Height (mm) of Keratinized Tissue After 25 Years of Function

Height of the keratinized tissue was measured (mm) using a ColorVue UNC12 Hu-Friedy probe on the buccal and lingual implant/abutment surfaces. Values (Mean ± SE) were calculated, recorded and compared between B and SW, between B and SC and between SW and SC for Configuration 1 (Brånemark® 2, Swede-Vent® 2, Screw-Vent® 1), Configuration 2 (Brånemark® 1, Swede-Vent® 2, Screw-Vent® 2), and Configuration 3 (Brånemark® 2, Swede-Vent® 1, Screw-Vent® 2)

Time frame: After 25 years (24.6 ± 0.19 years, mean ± SE) of function

Population: 22 participants in all Configurations contributed 110 implants (B=36, SW=38, SC=36). One implant (B Configuration 1) had fractured; two (B and SW Configuration 2) had technical issues. 107 implants were analysed after 25 years of function. Mean (Mean ± SE) values were calculated, recorded and compared between all B and all SW, between all B and all SC and between all SW and all SC implant units in all three Configurations

ArmMeasureGroupValue (MEAN)Dispersion
All Participants (Configurations 1, 2, and 3)Comparison of Soft Tissue Healing: Height (mm) of Keratinized Tissue After 25 Years of FunctionTotal 36 Screw-Vent® dental implant units analyzed for all three Configurations0.74 mm.Standard Error 0.1
All Participants (Configurations 1, 2, and 3)Comparison of Soft Tissue Healing: Height (mm) of Keratinized Tissue After 25 Years of FunctionTotal 35 Brånemark® dental implant units analyzed for all three Configurations0.67 mm.Standard Error 0.08
All Participants (Configurations 1, 2, and 3)Comparison of Soft Tissue Healing: Height (mm) of Keratinized Tissue After 25 Years of FunctionTotal 36 Swede-Vent® dental implant units analyzed for all three Configurations0.51 mm.Standard Error 0.08
Secondary

Comparison of Soft Tissue Healing: Probing Depth (mm) After 25 Years of Function

Using a ColorVue UNC12 Hu-Friedy probe, probing depth was measured (mm) on the buccal, lingual, mesial and distal implant/abutment surfaces. Values (Mean ± SE) were calculated, recorded and compared between B and SW, between B and SC and between SW and SC for Configuration 1(Brånemark® 2, Swede-Vent® 2, Screw-Vent® 1), Configuration 2 (Brånemark® 1, Swede-Vent® 2, Screw-Vent® 2), and Configuration 3 (Brånemark® 2, Swede-Vent ®1, Screw-Vent® 2)

Time frame: After 25 years (24.6 ± 0.19 years, mean ± SE) of function

Population: 22 participants in all Configurations contributed 110 units (B=36, SW=38, SC=36). 107 were analyzed (B=35. SW=36, SC=36). fBIC-MG was measured at mesial and distal sides of each unit after 25 years of function. Mean (Mean ± SE) values were calculated, recorded and compared between all B and all SW, between all B and all SC and between all SW and all SC dental implant units in all three Configurations

ArmMeasureGroupValue (MEAN)Dispersion
All Participants (Configurations 1, 2, and 3)Comparison of Soft Tissue Healing: Probing Depth (mm) After 25 Years of FunctionTotal 35 Brånemark® dental implant units analyzed for all three Configurations2.09 mmStandard Error 0.14
All Participants (Configurations 1, 2, and 3)Comparison of Soft Tissue Healing: Probing Depth (mm) After 25 Years of FunctionTotal 36 Swede-Vent® dental implant units analyzed for all three Configurations2.34 mmStandard Error 0.18
All Participants (Configurations 1, 2, and 3)Comparison of Soft Tissue Healing: Probing Depth (mm) After 25 Years of FunctionTotal 36 Screw-Vent® dental implant units analyzed for all three Configurations2.29 mmStandard Error 0.18
Other Pre-specified

Comparison of Two Measurement Systems Used to Evaluate Peri-implant Bone Healing After 25 Years of Function

Conventional peri-apical radiology and phosphor-plate digital technology (Digora System™, Digora OptimeTM, Sporedex Dental Co., Tuusula, Finland) were used with the standardized equipment to take peri-apical radiographs on 95 implant/abutment units (Camarda, et al., 2018; Bhaskaran, et al., 2005). Following calibration, the distance between the first-bone-to-implant-contact-point and the crestal-microgap (fBIC-MG) was measured (mm) at the mesial and distal aspects of each implant/abutment unit after 25 years of function. Values (Mean ± SE) fBIC-MG were recorded for each of the two measurement systems. ICC (Intraclass Correlation Coefficient, two-way, mixed effect model) and Bland-Altman Limits of agreement (Bland & Altman, 1986) were used to evaluate the level of agreement between the two systems

Time frame: After 25 years (24.6 ± 0.19 years, mean ± SE) of function

Population: Each of the 22 participants contributed five implants for a total of 110 B=36, SW=38, SC=36) for all three configurations. However, only 95 implants (19 participants) were analyzed (B=32, SW=32, SC=31) for all three configurations in order to compare the two measurement systems. One implant (SW, Configuration 1) was fractured. Two implants (one B and one SW, both Configuration 2) had technical issues with radiographs. Twelve implants could not be measured due to participant refusal

ArmMeasureGroupValue (MEAN)
All Participants (Configurations 1, 2, and 3)Comparison of Two Measurement Systems Used to Evaluate Peri-implant Bone Healing After 25 Years of FunctionICC (Intraclass Correlation Coefficient two-way, mixed effect model)0.93 Implants
All Participants (Configurations 1, 2, and 3)Comparison of Two Measurement Systems Used to Evaluate Peri-implant Bone Healing After 25 Years of FunctionBland-Altman Limits of agreement (Bland & Altman,1986)0.15 Implants

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026